Association between Toll-Like Receptor 9 -1237T/C Polymorphism and the Susceptibility of Inflammatory Bowel Diseases: A Meta-Analysis
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: The -1237T/C polymorphism of the Toll-like receptor 9 (TLR9) gene has been implicated in the susceptibility of inflammatorybowel diseases (IBDs), but the results remain conflicting. We further investigated this association via meta-analysis. Materials and Methods: Multiple electronic databases were extensively searched until February, 2015. The strength of associationwas evaluated by calculating the pooled odds ratios (ORs) and 95% confidence intervals (CIs). Results: A total of 2987 cases and 2388 controls from eight studies were analyzed. Overall, association was found between TLR9 -1237T/C polymorphism and the risk of IBDs when all the studies were pooled (recessive model, OR: 1.59, 95% CI: 1.02–2.47, p=0.04; homozygote comparison, OR: 1.62, 95% CI: 1.04–2.52, p=0.03; allele model, OR: 1.13, 95% CI: 1.00–1.27, p=0.05). Stratificationby ethnicity indicated an association between TLR9 -1237T/C polymorphism and IBDs risk in Caucasians (recessive model,OR: 1.59, 95% CI: 1.02–2.47, p=0.04; homozygote comparison, OR: 1.62, 95% CI: 1.04–2.52, p=0.03; allele model, OR: 1.12, 95% CI: 1.00–1.27, p=0.05). When stratified by disease type, significant correlation were only found in the Crohn’s disease subgroup (recessive model, OR: 1.69, 95% CI: 1.05–2.73, p=0.03; homozygote model, OR: 1.74, 95% CI: 1.07–2.82, p=0.02; allele model, OR: 1.15, 95% CI: 1.01–1.32, p=0.04). Conclusion: The present study suggested that the TLR9 -1237T/C polymorphism might act as a risk factor in the development of IBDs, particularly in Caucasians.
Abstract
Purpose: The -1237T/C polymorphism of the Toll-like receptor 9 (TLR9) gene has been implicated in the susceptibility of inflammatorybowel diseases (IBDs), but the results remain conflicting. We further investigated this association via meta-analysis. Materials and Methods: Multiple electronic databases were extensively searched until February, 2015. The strength of associationwas evaluated by calculating the pooled odds ratios (ORs) and 95% confidence intervals (CIs). Results: A total of 2987 cases and 2388 controls from eight studies were analyzed. Overall, association was found between TLR9 -1237T/C polymorphism and the risk of IBDs when all the studies were pooled (recessive model, OR: 1.59, 95% CI: 1.02–2.47, p=0.04; homozygote comparison, OR: 1.62, 95% CI: 1.04–2.52, p=0.03; allele model, OR: 1.13, 95% CI: 1.00–1.27, p=0.05). Stratificationby ethnicity indicated an association between TLR9 -1237T/C polymorphism and IBDs risk in Caucasians (recessive model,OR: 1.59, 95% CI: 1.02–2.47, p=0.04; homozygote comparison, OR: 1.62, 95% CI: 1.04–2.52, p=0.03; allele model, OR: 1.12, 95% CI: 1.00–1.27, p=0.05). When stratified by disease type, significant correlation were only found in the Crohn’s disease subgroup (recessive model, OR: 1.69, 95% CI: 1.05–2.73, p=0.03; homozygote model, OR: 1.74, 95% CI: 1.07–2.82, p=0.02; allele model, OR: 1.15, 95% CI: 1.01–1.32, p=0.04). Conclusion: The present study suggested that the TLR9 -1237T/C polymorphism might act as a risk factor in the development of IBDs, particularly in Caucasians.
참고문헌 (35)
- Kaser A, "Inflammatory bowel disease", Annu Rev Immunol, 28, pp.573~621 (2010)
- Baumgart DC, "Inflammatory bowel disease: clinical aspects and established and evolving therapies", Lancet, 369, pp.1641~1657 (2007)
- Loftus EV Jr, "Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences", Gastroenterology, 126, pp.1504~1517 (2004)
- Xavier RJ, "Unravelling the pathogenesis of inflammatory bowel disease", Nature, 448, pp.427~434 (2007)
- Khor B, "Genetics and pathogenesis of inflammatory bowel disease", Nature, 474, pp.307~317 (2011)
- Takeda K, "Toll-like receptors", Annu Rev Immu-nol, 21, pp.335~376 (2003)
- Akira S, "Toll-like receptor signalling", Nat Rev Immunol, 4, pp.499~511 (2004)
- Wagner H, "Interactions between bacterial CpG-DNA and TLR9bridge innate and adaptive immunity", Curr Opin Microbiol, 5, pp.62~69 (2002)
- Hampe J, "Fine mapping of the chromosome 3p susceptibility locus in inflammatory bowel disease", Gut, 48, pp.191~197 (2001)
- Omar AH, "Toll-like receptor 9 (TLR9) polymorphism associated with symptomatic malaria: a cohort study", Malar J, 11, pp.168~ (2012)
- Berghöfer B, "Common human Toll-like receptor 9 polymorphisms and haplotypes: association with atopy and functional relevance", Clin Exp Allergy, 35, pp.1147~1154 (2005)
- Novak N, "Putative association of a TLR9 promoter polymorphism with atopic eczema", Allergy, 62, pp.766~772 (2007)
- Hamann L, "Toll-like receptor (TLR)-9 promotor polymorphisms and atherosclerosis", Clin Chim Acta, 364, pp.303~307 (2006)
- 예병덕, "한국인에서 크론병과 Toll-Like Receptor 유전자의 연관성", 대한소화기학회지, 54(6), pp.377~383 (2009), 대한소화기학회
- Valverde-Villegas JM, "G2848A and T-1237C polymorphisms of the TLR9 gene and susceptibility to inflammatory bowel disease in patients from southern Brazil", Tissue Antigens, 83, pp.190~192 (2014)
- Török HP, "Crohn’s disease is associated with a toll-like receptor-9polymorphism", Gastroenterology, 127, pp.365~366 (2004)
- Török HP, "Epistasis between Toll-like receptor-9 polymorphisms and variants in NOD2 and IL23R modulates susceptibility to Crohn’s disease", Am J Gastroenterol, 104, pp.1723~1733 (2009)
- Shen XY, "Toll-like receptor gene polymorphisms and susceptibility to inflammatory bowel disease in Chinese Han and Caucasian populations", Zhonghua Yi Xue Za Zhi, 90, pp.1416~1420 (2010)
- Petermann I, "Interactions among genes influencing bacterial recognition increase IBD risk in a population-based New Zealand cohort", Hum Immunol, 70, pp.440~446 (2009)
- Hotte NS, "Patients with inflammatory bowel disease exhibit dysregulated responses to microbial DNA", PLoS One, 7, pp.e37932~ (2012)
- Hong J, "TLR2, TLR4 and TLR9 polymorphisms and Crohn’s disease in a New Zealand Caucasian cohort", J Gastroenterol Hepatol, 22, pp.1760~1766 (2007)
- Nakaoka H, "Meta-analysis of genetic association studies:methodologies, between-study heterogeneity and winner’s curse", J Hum Genet, 54, pp.615~623 (2009)
- Dai YE, "Contribution of polymorphisms in IKZF1 gene to childhood acute leukemia: a meta-analysis of 33 case-control studies", PLoS One, 9, pp.e113748~ (2014)
- Thakkinstian A, "Meta-analysis of molecular association studies: vitamin D receptor gene polymorphisms and BMD as a case study", J Bone Miner Res, 19, pp.419~428 (2004)
- Lau J, "Quantitative synthesis in systematic reviews", Ann Intern Med, 127, pp.820~826 (1997)
- Higgins JP, "Measuring inconsistency in meta-analyses", BMJ, 327, pp.557~560 (2003)
- Egger M, "Bias in metaanalysis detected by a simple, graphical test", BMJ, 315, pp.629~634 (1997)
- Abraham C, "Inflammatory bowel disease", N Engl J Med, 361, pp.2066~2078 (2009)
- Bouma G, "The immunological and genetic basis of inflammatory bowel disease", Nat Rev Immunol, 3, pp.521~533 (2003)
- Van Limbergen J, "The genetics of Crohn’s disease", Annu Rev Genomics Hum Genet, 10, pp.89~116 (2009)
- Duerr RH, "A genome-wide association study identifies IL23R as an inflammatory bowel disease gene", Science, 314, pp.1461~1463 (2006)
- Ogura Y, "A frameshift mutation in NOD2 associated with susceptibility to Crohn’s disease", Nature, 411, pp.603~606 (2001)
- Lazarus R, "Single-nucleotide polymorphisms in the Toll-like receptor 9 gene (TLR9): frequencies, pairwise linkage disequilibrium, and haplotypes in three U.S. ethnic groups and exploratory case-control disease association studies", Genomics, 81, pp.85~91 (2003)
- Hur JW, "Association study of Toll-like receptor 9 gene polymorphism in Korean patients with systemic lupus erythematosus", Tissue Antigens, 65, pp.266~270 (2005)
- Etem EO, "The investigation of toll-like receptor 3, 9 and 10 gene polymorphisms in Turkish rheumatoid arthritis patients", Rheumatol Int, 31, pp.1369~1374 (2011)